Abstract
One of the earliest descriptions of primary tumors of lymph nodes was by Thomas Hodgkin in 1832. His publication entitled “On Some Morbid Appearances of the Absorbent Glands and Spleen” reported the clinical characteristics and post mortem findings from seven patients with an unusual disease of lymph nodes (1). Some 30 yr later, the term “Hodgkin’s disease” was introduced by Sir Samuel Wilks in honor of the work of Thomas Hodgkin (2).
Today, the malignant lymphomas are regarded as a heterogeneous group of neoplasms, which can be broadly categorized into two groups: Hodgkin’s lymphoma (formerly Hodgkin’s disease) and non-Hodgkin’s lymphoma. These neoplasms most often arise in lymphoid tissues such as lymph nodes and spleen, but could arise virtually anywhere in the body. M a lignant lym-phoma comprises approx 5% of new cancer cases in the United States annually, with approx 53,400 new cases of non-Hodgkin’s lymphoma and 7,600 new cases of Hodgkin’s lym-phoma expected in 2003 (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hodgkin, T. On some morbid appearances of the absorbent glands and spleen. Med–Chir. Trans. 17:69–97, 1832.
Wilks, S. Cases of enlargement of the lymphatic glands and spleen (or, Hodgkin’s disease), with remarks. Guys Hosp. Rep. 11:56–67, 1865.
Jemal, A., Murray, T., Samuels, A., et al. Cancer statistics, 2003. CA Cancer J. Clin 53:5–26, 2003.
Bertoli, L. F., and Burrows, P. D. Normal B-lineage cells: their differentiation and identification. Clin. Lab. Med. 8:15–30, 1988.
Denning, S. M. and Haynes, B. F. Differentiation of human T cells. Clin. Lab. Med. 8:1–14, 1988.
Jaffe, E. S., Harris, N. L., Stein, H., and Vardiman, J. eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoeitic and Lymphoid Tissues. IARC, Lyon, 2001.
Jaffe, E. S. The role of immunophenotypic markers in the classification of non-Hodgkin’s lymphomas. Semin. Oncol. 17:11–19, 1990.
Campana, D. and Pui, C-H. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 85:1416–1434, 1995.
Sen, F., Vega, F, and Medeiros, L. J. Molecular genetic methods in the diagnosis of hematologic neoplasms. Semin. Diagn. Pathol. 19(2):, 72–93, 2002.
Cooper, M. D. B lymphocytes: normal development and function. N. Engl. J. Med. 317:1452–1456, 1987.
Pan, L., Cesarman, E., and Knowles, D. M. Antigen receptor genes: structure, function, and genetic analysis of their rearrangements, Neoplastic Hematopathology, Knowles, D. M., ed., Lippincott, Williams and Wilkins, Philadelphia, PA, pp. 307–328, 2001.
Foon, K. A. and Todd, R. F. Immunologic classification of leukemia and lymphoma. Blood 68:1–31, 1986.
Spits, H., Lanier, L. L., and Phillips, J. H. Development of human T and natural killer cells. Blood 85:2654–2670, 1995.
Cossman, J., Uppenkamp, M., Sundeen, J., Coupland, R., and Raffeld, M. Molecular genetics and the diagnosis of lymphoma. Arch. Pathol. Lab. Med. 112:117–127, 1988.
Cossman, J., and Uppenkamp, M. T cell gene rearrangements and the diagnosis of T cell neoplasms. Clin. Lab. Med. 8:31–44, 1988.
Royer, H. D. and Reinherz, E. L. T lymphocytes: ontogeny, function, and relevance to clinical disorders. N. Eng. J. Med. 317: 1136–1142, 1987.
Gill, J. I. and Gulley, M. L. Immunoglobulin and T cell receptor gene rearrangement. Hematol. Oncol. Clin. North Am. 8:751–770, 1994.
Rezuke, W. N., Abernathy, E. C., and Tsongalis, G. J. Molecular diagnosis of B and T cell lymphomas: fundamental principles and clinical applications. Clin. Chem. 43:1814–1823, 1997.
Cossman, J., Zehnbauer, B., Garrett, C. T., et al. Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study. Am. J. Clin. Pathol. 95:347–354, 1991.
Farkas, D. H. The Southern blot: application to the B and T cell gene rearrangement test. Lab. Med. 23:723–729, 1992.
Beishuizen, A., Verhoeven, M. J., Mol, E. J., and van Dongen, J. J. M. Detection of immunoglobulin kappa light chain gene rearrangement patterns by Southern blot analysis. Leukemia 8:2228–2236, 1994.
Hodges, K. A., Kosciol, C. M., Rezuke, W. N., Abernathy, E. C., Pastuszak, W. T., and Tsongalis, G. T. Chemiluminescent detection of gene rearrangements in hematologic malignancy. Ann. Clin. Lab. Sci. 26:114–118, 1996.
Medeiros, L. J. and Weiss, L. M. The utility of the polymerase chain reaction as a screening method for the detection of antigen receptor gene rearrangements. Hum. Pathol. 25:1261–1263, 1994.
Macintyre, E. A. The use of the polymerase chain reaction in hematology. Blood Rev. 3:201–210, 1989.
Weiss, L. M. and Spagnolo, D. V. Assessment of clonality in lym-phoid proliferations. Am. J. Pathol. 142:1679–1682, 1993.
McCarthy, K. P., Sloane, J. P., Kabarowski, J. H. S., Matutes, E., and Wiedemann, L. M. The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am. J. Pathol. 138:821–828, 1991.
Ben-Ezra, J. Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin’s lymphomas and leukemias. Leuk. Lymph. 7:289–295, 1992.
Diss, T. C., Peng, H., Wotherspoon, A. C., Isaacson, P. G., and Pan, L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selction and lymphoma type. J. Pathol. 169:291–295, 1993.
Segal, G. H., Jorgensen, T., Masih, A. S., and Braylan, R. C. Optimal primer selection for clonality assessment by polymerase chain reaction analysis. Low grade B-cell lymphoproliferative disorders of non-follicular center cell type. Hum. Pathol. 25:1269–1275, 1994.
Slack, I. N., McCarthy, K. P., Wiedemann, L. M., and Sloane, J. P. Evaluation of sensitivity, specificity, and reproducibility of an optimized method for detecting clonal rearrangements of immunoglob-ulin and T-cell receptor genes in formalin-fixed, paraffin-embedded sections. Diagn. Mol. Pathol. 2:223–232, 1993.
Algara, P., Caridad, S., Martinez, P., et al. Value of PCR detection of TCRγ gene rearrangments in the diagnosis of cutaneous lymphocytic infiltrates. Diagn. Mol. Pathol. 3:275–282, 1994.
Achille, A., Scarpa, A., Montresor, M., et al. Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn. Mol. Pathol. 4:14–24, 1995.
Fodinger, M., Buchmayer, H., Schwarzinger, I., et al. Multiplex PCR for rapid detection of T-cell receptor gamma chain gene rearrangements in patients with lymphoproliferative diseases. Br. J. Haematol. 94:136–139, 1996.
Lozano, M. D., Tierens, A., Greiner, T. C., et al. Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction. Cancer 77:1349–1355, 1996.
Abdel-Reheim, F. A., Edwards, E., and Arber, D. A. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma. Arch. Pathol. Lab. Med. 120:357–363, 1996.
Lombardo, J. F., Hwang, T. S., Maiese, R. L., Millson, A., and Segal, G. H. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: Intermediate and high grade B-cell neoplasms. Hum. Pathol. 27:373–380, 1996.
Diaz-Cano, S. PCR-based alternative for diagnosis of immunoglob-ulin heavy chain gene rearrangement. Diagn. Mol. Pathol. 5:3–9, 1996.
38. Ritter, J. H., Wick, M. R., Adesokan, P. N., et al. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangements. Am. J. Clin. Pathol. 108:60–68, 1997.
Ashton-Key, M., Diss, T. C., Du, M. Q., et al. The value of the poly-merase chain reaction in the diagnosis of cutaneous T-cell infiltrates. Am. J. Surg. Pathol. 21:743–747, 1997.
Tsongalis, G. J., Stevenson, A. J., Hodges, K. A., and Rezuke, W. N. Clonal analysis of B-cell lymphoproliferative disorders. Eur. J. Lab. Med. 3:142–145, 1998.
Sioutos, N., Bagg, A., Michaud, G. Y., et al. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglob-ulin heavy-chain gene rearrangements. Diagn. Mol. Pathol. 4:8–13, 1995.
Lehman, C. M., Sarago, C., Nasim, S., Comerford, J., Karcher, D. S., and Garrett, C. T. Comparison of PCR with Southern hybridization for the routine detection of immunoglobulin heavy chain gene rearrangements. Am. J. Clin. Pathol. 103:171–176, 1995.
Tbakhi, A. and Tubbs, R. R. Utility of the polymerase chain reaction in detecting B cell clonality in lymphoid neoplasms. Cancer 77:1223–1225, 1996.
Kuppers, R., Zhao, M., Rajewsky, K., and Hansmann, M. L. Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. Am. J. Pathol. 143:230–239, 1993.
Inghirami, G., Szabolcs, M. J., Yee, H. T., Corradini, P., Cesarman, E., and Knowles, D. M. Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin’s lymphomas and leukemias in fresh, unfixed and formalin fixed, paraffin-embedded tissue by polymerase chain reaction. Lab. Invest. 68:746–757, 1993.
Reed, T. J., Reid, A., Wallberg, K., O’Leary, T. J., and Frizzera, G. Determination of B cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagn. Mol. Pathol. 2:42–49, 1993.
Segal, G. H., Jorgensen, T., Scott, M., and Braylan, R. C. Optimal primer selection for clonality assessement by polymerase chain reaction analysis: II. Follicular lymphomas. Hum. Pathol. 25: 1276–1282, 1994.
Siebert, R. and Weber-Matthiesen, K. Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas. Histochem. Cell. Biol. 108:391–402, 1997.
Kluin, P. H. and Schuuring, E. FISH and related techniques in the diagnosis of lymphoma. Cancer Surv. 30:3–20, 1997.
Remstein, E. D., Kurtin, P. J., Buno, I., et al. Diagnostic utility of fluorescence in situ hybridization in mantle cell lymphoma. Br. J. Haematol. 110:856–862, 2000.
Medeiros, L. J. and Carr, J. Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch. Pathol. Lab. Med. 123:1189–1207, 1999.
Tam, W. and Dalla-Favera, R. Protooncogenes and tumor suppressor genes in hematopoietic malignancies, in Neoplastic Hematopathology, Knowles, D. M., ed., Lippincott, Williams and Wilkins, Philadelphia, PA, 2001, pp. 329–364.
Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879–886, 1992.
Crisan, D., Chen, S-T., and Weil, S. C. Polymerase chain reaction in the diagnosis of chromosomal breakpoints. Hematol. Oncol. Clin. North. Am. 8:725–750, 1994.
Ngan, B-Y., Nourse, J., and Cleary, M. L. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 73:1759–1762, 1989.
Cory, S., Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv. Cancer Res. 47:189–234, 1986.
Adams, J. M., Gerondakis, S., Webb, E., Mitchell, J., Bernard, O., and Cory, S. Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc. Natl. Acad. Sci. USA 79:6966–6970, 1982.
Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. M., and Cory, S. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc. Natl. Acad. Sci. USA 80:1982–1986, 1983.
Taub, R., Kirsch, I., Morton, C., et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 79:7837–7841, 1982.
Dalla-Favera, R., Martinotti, S., Gallo, R. C., Erikson, J., and Croce, C. M. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B cell lymphomas. Science 219:963–967, 1983.
Bernard, O. Cory, S., Gerondakis, S., Webb, E., and Adams, J. M. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumors. EMBO J. 2:2375–2383, 1983.
Cory, S., Vaux, D. L., Strasser, A., Harris, A. W., and Adams, J. M. Insights from Bcl-2 and myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 59:1685s–1692s, 1999.
Yano, T., Sander, C. A., Clark, H. M., Dolezal, M. V., Jaffe, E. S., and Raffeld, M. Clustered mutations in the second exon of the myc gene in sporadic Burkitt’s lymphoma. Oncogene 8:2741–2748, 1993.
Cheng, S. W. G., Davies, K. P., Yung, E., Beltran, R. J., Yu, J., and Kalpana, G.V. C-myc interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 22:102–105, 1999.
Facchini, L.M. and Penn, l. Z. The molecular role of myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12:633–651, 1998.
Henriksson, M. and Luscher, B. Proteins of the myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109–182, 1996.
Hecht, J. L. and Aster, J. C. Molecular biology of Burkitt’s lymphoma. J. Clin. Oncol. 18:3707–3721, 2000.
Williams, M. E., Westermann, C. D., and Swerdlow, S. H. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 76:1387–1391, 1990.
Armitage, J. O. A clinical evaluation of the International Study Group Classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood 89(11): 3909–3918, 1997.
Fiel-Gan, M. D., Almeida, L., Rose, D. C., et al. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma. Int. J. Mol. Med. 3:373–379, 1999.
Seto, M., Yamamoto, K., Iida, S., et al. Gene rearrangement and overexpression of PRAD-1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7:1401–1406, 1992.
Motokura, T., Bloom, T., Kim, H. G., et al. A novel cyclin encoded by bcl-1 linked candidate oncogene. Nature 350:512–515, 1991.
Argatoff, L. H., Connors, J. M., Klasa, R. J., Horsman, D. E., and Gascoyne, R. D. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89:2067–2078, 1997.
Chibbar, R., Leung, K., McCormick, S., et al. bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5 fixed tissue, by polymerase chain reaction and Southern transfer analysis. Mod. Pathol. 11:1089–1097, 1998.
Molot, R. J., Meeker, T. C., Wittwer, C. T., et al. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 83:1626–1631, 1994.
Williams, M. E., Swerdlow, S. H., Rosenberg, C. L., and Arnold, A. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res. 52:5541s–5544s, 1992.
Williams, M. E., Meeker, T. C., and Swerdlow, S. H. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 78:493–498, 1991.
Williams, M. E., Swerdlow, S. H., and Meeker, T. C. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 7:1437–1440, 1993.
Campo, E., Raffeld, M., and Jaffe, E. S. Mantle cell lymphoma. Semin. Hematol. 36(2):115–127, 1999.
Swerdlow, S. H. and Williams, M. E. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum. Pathol. 33(1):7–20, 2002.
Hanken, R. C. and Hunter S. V. Mantle cell lymphoma: molecular and immunophenotypic diagnostic aids. Arch. Pathol. Lab. Med. 123:1182–1188, 1999.
Baron, B. W., Stanger, R. R., Hume, E., et al. Bcl-6 encodes a sequence specific DNA binding protein. Genes Chromosomes Cancer 13:221–224, 1995.
Kerckaert, J. P., Deweindt, C., Tilly, H., et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat. Genet. 5:66–70, 1993.
Ye, B. H., Rao, P. H., Chaganti, R. S. K., and Dalla-Favera, R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B cell lymphoma. Cancer Res. 53:2732–2735, 1993.
Kawamata, N., Nakamura, Y., Miki, T., et al. Detection of chimaeric transcripts of the immunoglobulin heavy chain and bcl6 genes by reverse transcriptase polymerase chain reaction in B cell non-Hodgkin’s lymphomas. Br. J. Haematol. 100:484–489, 1998.
Muramatsu, M., Akasaka, T., Kadowaki, N., et al. Rearrangement of the bcl6 gene in B cell lymphoid neoplasms: comparison with lymphomas associated with bcl2 rearrangement. Br. J. Haematol. 93:911–920, 1996.
Niu, H. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol. 20(4):155–66, 2002.
Cattoretti, G., Chang, C. C., Cechova, K., et al. BCL-6 protein is expressed in germinal-center B cells. Blood 86(1):45–53, 1995.
Lo Coco, F., Ye, B. H., Lista, F., et al. Rearrangements of the BCL-6 gene in diffuse large cell non-Hodgkin’s lymphoma. Blood 83(7):1757–1759, 1994.
Mason, D. Y., Bastard, C., Romokh, R., et al. CD30-positive large cell lymphomas (“Ki-1 lymphoma”) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 74:161, 1990.
Morris, S. W., Kirstein, M. N., Valentine, M. B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263:1281, 1994.
Lamant, L., Meggetto, F., Al Saati, T., et al. High incidence of the t(2;5)(q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin’s disease. Comparison of cytogenetic analysis, reverse transcriptase polymerase chain reaction, and P-80 immunostaining. Blood 87:284–291, 1996.
Jaffe, E. S. Anaplastic large cell lymphoma: the shifting sands of hematopathology. Mod. Pathol. 14(3):219–228, 2001.
Kutok, J. L. and Aster, J. C. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J. Clin. Oncol. 20(17):3691–3702, 2002.
Stein, H., Foss, H. D., Durkop H., et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic and clinical features. Blood 96(12):3681–3695, 2000.
Haluska, F. G., Brufsky, A. M., and Canellos, G. P. The cellular biology of the Reed-Sternberg cell. Blood 84:1005–1019, 1994.
Chan, W. C. Cellular origin of nodular lymphocyte-predominant Hodgkin’s lymphoma: immunophenotypic and molecular studies. Semin. Hematol. 36(3):242–252, 1999.
Stein, H. and Hummel, M. Cellular origin and clonality of classic Hodgkin’s lymphoma: immunophenotypic and molecular studies. Semin. Hematol. 36(3):233–241, 1999.
Marafioti, T., Hummel, M., Foss H. D., et al. Hodgkin and Reed–Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglob-ulin gene rearrangements but defective immunoglobulin transcription. Blood 95(4):1443–1450, 2000.
Weiss, L. M., Strickler, J. G., Hu, E., Warnke, R. A., and Sklar, J. Immunoglobulin gene rearrangements in Hodgkin’s disease. Hum. Pathol. 17:1009–1014, 1986.
Marafioti, T., Anagnostopoulos, I., Foss, H. D., et al. Origin of nodular lymphocyte-predominant Hodgkin’s disease from a clonal expansion of highly mutated germinal-center B cells. N. Engl. J. Med. 337(7):453–458, 1997.
Corradini, P., Ladetto, M., Pileri, A., and Tarella, C. Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphoma: a critical reappraisal of molecular strategies. Leukemia 13:1691–1695, 1999.
Negrin, R. S. and Blume, K. G. The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 78:255–258, 1991.
Sklar, J. Polymerase chain reaction: The molecular microscope of residual disease. J. Clin. Oncol. 9:1521–1524, 1991.
Corradini, P., Stolfi, M., Cherasco, C., et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin’s lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 89:724–731, 1997.
Wu, G. Q., Sharp, J. G., Wu, G., et al. The detection of minimal lymphoma by molecular and combined culture-molecular methods. Br. J. Haematol. 99:873–881, 1997.
Dolken, G. Detection of minimal residual disease. Adv. Cancer Res. 82:133–185, 2001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rezuke, W.N., Tsongalis, G.J. (2006). Molecular Genetic Applications to the Diagnosis of Lymphoma. In: Coleman, W.B., Tsongalis, G.J. (eds) Molecular Diagnostics. Humana Press. https://doi.org/10.1385/1-59259-928-1:393
Download citation
DOI: https://doi.org/10.1385/1-59259-928-1:393
Publisher Name: Humana Press
Print ISBN: 978-1-58829-356-5
Online ISBN: 978-1-59259-928-8
eBook Packages: MedicineMedicine (R0)